These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Colony and Single Cell Level Analysis of the Heterogeneous Response of Altamirano S; Simmons C; Kozubowski L Front Cell Infect Microbiol; 2018; 8():203. PubMed ID: 29971221 [No Abstract] [Full Text] [Related]
10. Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro. Peng CA; Gaertner AAE; Henriquez SA; Fang D; Colon-Reyes RJ; Brumaghim JL; Kozubowski L PLoS One; 2018; 13(12):e0208471. PubMed ID: 30532246 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ PLoS One; 2012; 7(3):e33022. PubMed ID: 22412978 [TBL] [Abstract][Full Text] [Related]
12. Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans. Dbouk NH; Covington MB; Nguyen K; Chandrasekaran S BMC Microbiol; 2019 Nov; 19(1):243. PubMed ID: 31694529 [TBL] [Abstract][Full Text] [Related]
13. With age comes resilience: how mitochondrial modulation drives age-associated fluconazole tolerance in Yoo K; Bhattacharya S; Oliveira NK; Pereira de Sa N; Matos GS; Del Poeta M; Fries BC mBio; 2024 Sep; 15(9):e0184724. PubMed ID: 39136442 [TBL] [Abstract][Full Text] [Related]
14. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592 [TBL] [Abstract][Full Text] [Related]
15. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans. Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169 [No Abstract] [Full Text] [Related]
16. Involvement of mitochondrial aerobic respiratory activity in efflux-mediated resistance of C. albicans to fluconazole. Guo H; Xie SM; Li SX; Song YJ; Zhong XY; Zhang H J Mycol Med; 2017 Sep; 27(3):339-344. PubMed ID: 28483448 [TBL] [Abstract][Full Text] [Related]
17. Achieving Resilience in Aging: How Mitochondrial Modulation Drives Age-associated Fluconazole Tolerance in Yoo K; Oliveira NK; Bhattacharya S; Fries BC bioRxiv; 2024 Mar; ():. PubMed ID: 38585804 [TBL] [Abstract][Full Text] [Related]
18. Synergistic mechanism for tetrandrine on fluconazole against Candida albicans through the mitochondrial aerobic respiratory metabolism pathway. Guo H; Xie SM; Li SX; Song YJ; Lv XL; Zhang H J Med Microbiol; 2014 Jul; 63(Pt 7):988-996. PubMed ID: 24790082 [TBL] [Abstract][Full Text] [Related]
19. From the environment to the host: How non-azole agrochemical exposure affects the antifungal susceptibility and virulence of Cryptococcus gattii. Bastos RW; Freitas GJC; Carneiro HCS; Oliveira LVN; Gouveia-Eufrasio L; Santos APN; Moyrand F; Maufrais C; Janbon G; Santos DA Sci Total Environ; 2019 Sep; 681():516-523. PubMed ID: 31121401 [TBL] [Abstract][Full Text] [Related]
20. Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole. Kano R; Okubo M; Hasegawa A; Kamata H Med Mycol; 2017 Nov; 55(8):877-882. PubMed ID: 28927230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]